Neoleukin Therapeutics Announces Preclinical Data Highlighting Activity of NL-201 in Hematologic Malignancies at 63rd American Society of Hematology…

Poster presentation highlights NL-201 activity in multiple myeloma stem cell transplant model Abstract reports activity of NL-201 as monotherapy and anti-PD1 combination in non-Hodgkin lymphoma model SEATTLE, Dec. 11, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., Neoleukin (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the presentation of preclinical data on NL-201 in multiple myeloma at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition taking place virtually and in person December 11-14, 2021. Additionally, a published abstract in Blood reports on NL-201 antitumor activity in preclinical studies of non-Hodgkin lymphoma

Read more
Ten Problems with Embryonic Stem Cell Research | The …

Embryonic stem cells are the basic building blocks for some 260 types of cells in the body and can become anything: heart, muscle, brain, skin, blood. Researchers hope that by guiding stem cells in the laboratory into specific cell types, they can be used to treat diabetes, Parkinson's disease, heart disease, or other disorders. The primary clinical source is the aborted fetus and unused embryos currently housed in frozen storage at IVF facilities.

Read more
Stem Cells Australia | Australian research, stem cell …

How are new treatments developed? If you have seen a stem cell treatment advertised, featured in the media, or mentioned to you by a friend or fellow patient, it can be hard to work out if it may be an option for you. Although there is a lot of attention surrounding the potential of stem cells, in reality, the range of diseases for which there are current proven stem cell treatments is quite small

Read more
Ethical issues cloud case report of unproven stem cell therapy for autism – Spectrum

Cell service: Parent reports suggest that a stem cell therapy eased their childrens autism traits, but experts remain skeptical. Cavan Images / Getty Images Undisclosed financial conflicts of interest and a lack of proper clearance mar a new study that injected four autistic children with stem cells from their own bone marrow, bioethicists say. The study, which was published in October in Frontiers in Pediatrics, did not undergo ethical review and approval by an institutional review board (IRB), a critical step for research involving human participants

Read more
Mesenchymal Stem Cells Market Size 2021 Emerging Technologies, Global Regions with Industry Share Analysis, Gross Margin, Regional Demand and Forecast…

Report Ocean presents a new report on Mesenchymal Stem Cells Market size, share, growth, industry trends, and forecast 2026, covering various industry elements and growth trends helpful for predicting the markets future. The global mesenchymal stem cells market size to reach USD 2,518.5 Million by 2026, growing at a CAGR of 7.0% during forecast period, according to a new research report published .

Read more
For children, young adults with recurrent AML, immunotherapy shows promise Washington University School of Medicine in St. Louis – Washington…

Visit the News Hub Natural killer cells could help young patients with few treatment options Researchers at Washington University School of Medicine in St. Louis have shown, in a small clinical trial, that pre-activated natural killer cells can help some children and young adults with recurrent AML and few other treatment options.

Read more
UEA researchers reveal how immune cells use the bodys fat stores to fight infection – News-Medical.net

New research from the University of East Anglia and Quadram Institute reveals how our immune cells use the bodys fat stores to fight infection. Image Credit: University of East Anglia The research, published today in the journal Nature Communications, could help develop new approaches to treating people with bacterial infections. The research team say their work could one day help treat infections in vulnerable and older people.

Read more